210 related articles for article (PubMed ID: 11996812)
1. Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study.
Vandervoort J; Ludwig A
Int J Pharm; 2002 May; 238(1-2):77-92. PubMed ID: 11996812
[TBL] [Abstract][Full Text] [Related]
2. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake.
Sahoo SK; Panyam J; Prabha S; Labhasetwar V
J Control Release; 2002 Jul; 82(1):105-14. PubMed ID: 12106981
[TBL] [Abstract][Full Text] [Related]
3. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.
Wang N; Wu XS; Li JK
Pharm Res; 1999 Sep; 16(9):1430-5. PubMed ID: 10496661
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of poly(D,L-lactic-co-glycolic Acid) microspheres containing flurbiprofen sodium.
Samati Y; Yüksel N; Tarimci N
Drug Deliv; 2006; 13(2):105-11. PubMed ID: 16423798
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of melittin-loaded poly (DL-lactic acid) or poly (DL-lactic-co-glycolic acid) microspheres made by the double emulsion method.
Cui F; Cun D; Tao A; Yang M; Shi K; Zhao M; Guan Y
J Control Release; 2005 Oct; 107(2):310-9. PubMed ID: 16255081
[TBL] [Abstract][Full Text] [Related]
6. Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA.
Perez C; Sanchez A; Putnam D; Ting D; Langer R; Alonso MJ
J Control Release; 2001 Jul; 75(1-2):211-24. PubMed ID: 11451511
[TBL] [Abstract][Full Text] [Related]
7. Influence of the homogenisation procedure on the physicochemical properties of PLGA nanoparticles.
Vandervoort J; Yoncheva K; Ludwig A
Chem Pharm Bull (Tokyo); 2004 Nov; 52(11):1273-9. PubMed ID: 15516745
[TBL] [Abstract][Full Text] [Related]
8. Optimization of PLGA nanoparticles formulation containing L-DOPA by applying the central composite design.
Zhou YZ; Alany RG; Chuang V; Wen J
Drug Dev Ind Pharm; 2013 Feb; 39(2):321-30. PubMed ID: 22607101
[TBL] [Abstract][Full Text] [Related]
9. Surface characterization of poly(alpha-hydroxy acid) microspheres prepared by a solvent evaporation/extraction process.
Boury F; Marchais H; Benoit JP; Proust JE
Biomaterials; 1997 Jan; 18(2):125-36. PubMed ID: 9022959
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
Ravi Kumar MN; Bakowsky U; Lehr CM
Biomaterials; 2004 May; 25(10):1771-7. PubMed ID: 14738840
[TBL] [Abstract][Full Text] [Related]
11. Formulation and in-vitro characterization of retinoic acid loaded poly (lactic-co-glycolic acid) microspheres.
Cirpanli Y; Unlü N; Caliş S; Hincal AA
J Microencapsul; 2005 Dec; 22(8):877-89. PubMed ID: 16423759
[TBL] [Abstract][Full Text] [Related]
12. Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid.
Keum CG; Noh YW; Baek JS; Lim JH; Hwang CJ; Na YG; Shin SC; Cho CW
Int J Nanomedicine; 2011; 6():2225-34. PubMed ID: 22114486
[TBL] [Abstract][Full Text] [Related]
13. Formulation and evaluation of sustained release microspheres of poly-lactide-co-glycolide containing tamoxifen citrate.
Sehra S; Dhake AS
J Microencapsul; 2005 Aug; 22(5):521-8. PubMed ID: 16361195
[TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation of poly (D, L-lactic acid) (PLA) or D, L-lactide/glycolide copolymer (PLGA) microspheres with estradiol.
Xinteng Z; Weisan P; Ruhua Z; Feng Z
Pharmazie; 2002 Oct; 57(10):695-7. PubMed ID: 12426951
[TBL] [Abstract][Full Text] [Related]
15. Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method.
Murakami H; Kobayashi M; Takeuchi H; Kawashima Y
Int J Pharm; 1999 Oct; 187(2):143-52. PubMed ID: 10502620
[TBL] [Abstract][Full Text] [Related]
16. Preparation factors affecting the properties of polylactide nanoparticles: a factorial design study.
Vandervoort J; Ludwig A
Pharmazie; 2001 Jun; 56(6):484-8. PubMed ID: 11446170
[TBL] [Abstract][Full Text] [Related]
17. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
[TBL] [Abstract][Full Text] [Related]
18. Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats.
Sonaje K; Italia JL; Sharma G; Bhardwaj V; Tikoo K; Kumar MN
Pharm Res; 2007 May; 24(5):899-908. PubMed ID: 17377747
[TBL] [Abstract][Full Text] [Related]
19. Preparation and biodegradable properties of hydroxyapatite nanoparticle composite coated with poly lactic-co-glycolic acid/polyvinyl alcohol for bone regeneration.
Istikharoh F; Sujuti H; Mustamsir E; Swastirani A
Dent Med Probl; 2020; 57(4):363-367. PubMed ID: 33448162
[TBL] [Abstract][Full Text] [Related]
20. Surface modification of PLGA nanoparticles by carbopol to enhance mucoadhesion and cell internalization.
Surassmo S; Saengkrit N; Ruktanonchai UR; Suktham K; Woramongkolchai N; Wutikhun T; Puttipipatkhachorn S
Colloids Surf B Biointerfaces; 2015 Jun; 130():229-36. PubMed ID: 25937384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
